Teva Pharmaceutical Industries EBIT 2010-2024 | TEVA

Teva Pharmaceutical Industries EBIT for the quarter ending September 30, 2024 was $-0.049B, a 114.2% decline year-over-year.

  • Teva Pharmaceutical Industries 2023 EBIT was 0.433B, a 119.71% decline from 2022.
  • Teva Pharmaceutical Industries 2022 EBIT was -2.197B, a 228.1% decline from 2021.
  • Teva Pharmaceutical Industries 2021 EBIT was 1.715B, a 148.03% decline from 2020.

EBIT can be defined as earnings before interest and taxes.

Teva Pharmaceutical Industries EBIT 2010-2024 | TEVA

  • Teva Pharmaceutical Industries 2023 EBIT was 0.433B, a 119.71% decline from 2022.
  • Teva Pharmaceutical Industries 2022 EBIT was -2.197B, a 228.1% decline from 2021.
  • Teva Pharmaceutical Industries 2021 EBIT was 1.715B, a 148.03% decline from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$12B
BridgeBio Pharma (BBIO)$4.3B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.1B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$434M
Personalis (PSNL)$261M
Assembly Biosciences (ASMB)$98M
Sol-Gel Technologies (SLGL)$12M
Evoke Pharma (EVOK)$7M
Teligent (TLGT)$0M